Indeed, in vitro silencing of PRPF8 reduced the CCDC50S/CCDC50 and KLF6SV1/KLF6 ratios in the three HCC cell lines used, indicating lower expression of the oncogenic splice variants (Fig. 3h). This evidence concerns the gene PRPF8 and hepatocellular carcinoma.